SCHEMBL7463426

SCHEMBL7463426

c1cc(Nc2nccc(-c3ccncc3)n2)cc(-n2ccnc2)c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 9/20 0.80
BCR P11274 9/20 0.80
PRKCA P17252 6/20 0.80
SRC P12931 5/20 0.80
PRKCD Q05655 4/20 0.80
PDGFRB P09619 1/20 0.80
PDGFRA P16234 1/20 0.80
IKBKB O14920 1/20 0.59
JAK2 O60674 2/20 0.49
EGFR P00533 2/20 0.49
MAPK10 P53779 1/20 0.47
PIK3CA P42336 3/20 0.47
PIK3CG P48736 3/20 0.47
PIK3CB P42338 1/20 0.47
PRKACA P17612 1/20 0.47
PRKACG P22612 1/20 0.47
PRKACB P22694 1/20 0.47
MKNK1 Q9BUB5 1/20 0.46
CAMK2D Q13557 1/20 0.46
PIK3C3 Q8NEB9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6256104 0.89 ABL1 (1.00) ABL1BCRPRKCASRCPRKCD
SCHEMBL4902560 0.88 ABL1 (0.72) ABL1BCRPRKCASRCPRKCD
SCHEMBL7462511 0.87 IKBKB (0.64) ABL1BCRPRKCASRCPRKCD
SCHEMBL7465915 0.85 ABL1 (0.71) ABL1BCRPRKCASRCPRKCD
SCHEMBL7469128 0.84 SRC (0.67) ABL1BCRPRKCASRCPRKCD
SCHEMBL8592858 0.84 ABL1 (0.67) ABL1BCRPRKCASRCPRKCD
SCHEMBL8554283 0.83 ABL1 (0.69) ABL1BCRPRKCASRCPRKCD
SCHEMBL4902208 0.83 ABL1 (0.67) ABL1BCRPRKCASRCPRKCD
SCHEMBL4902199 0.79 ABL1 (0.63) ABL1BCRPRKCASRCPRKCD
SCHEMBL4905227 0.79 ABL1 (0.70) ABL1BCRPRKCASRCPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0233461-B2 4,5,6-Substituted-2-pyrimidinamines AMERICAN CYANAMID CO (US) 2002-05-29 EP claimed
EP-0453731-B1 Improved process for the synthesis of N-3-(1H-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidinamines AMERICAN CYANAMID CO (US) 1998-08-26 EP claimed
EP-0233461-B1 4,5,6-Substituted-2-pyrimidinamines AMERICAN CYANAMID CO (US) 1996-03-20 EP claimed
EP-0453731-A2 Improved process for the synthesis of N-3-(1H-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidinamines AMERICAN CYANAMID COMPANY (US) 1991-10-30 EP claimed
US-4788195-A TREATING ASTHMA, ALLERGIC DISEASES, INFLAMMATION AND DIABETES IN MAMMALS AMERICAN CYANAMID COMPANY (US) 1988-11-29 US claimed
EP-0233461-A2 4,5,6-Substituted-2-pyrimidinamines AMERICAN CYANAMID COMPANY (US) 1987-08-26 EP claimed
EP-0233461-B2 4,5,6-Substituted-2-pyrimidinamines AMERICAN CYANAMID CO (US) 2002-05-29 EP disclosed
EP-0687251-B1 1,3-DIHYDROINDOL-2-ONE DERIVATIVES SUBSTITUTED IN POSITION 3 BY A NITROGEN GROUP AS VASOPRESSIN AND/OR OCYTOCINE AGONISTS AND/OR ANTAGONISTS SANOFI SYNTHELABO (FR) 2002-02-27 EP disclosed
EP-0453731-B1 Improved process for the synthesis of N-3-(1H-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidinamines AMERICAN CYANAMID CO (US) 1998-08-26 EP disclosed
US-5594023-A 1,3-dihydroindol-2-one derivatives substituted in the 3-position by a nitrogen-containing group, their preparation and the pharmaceutical compositions in which they are present SANOFI (FR) 1997-01-14 US disclosed
EP-0233461-B1 4,5,6-Substituted-2-pyrimidinamines AMERICAN CYANAMID CO (US) 1996-03-20 EP disclosed
WO-1995018105-A1 1,3-DIHYDROINDOL-2-ONE DERIVATIVES SUBSTITUTED IN POSITION 3 BY A NITROGEN GROUP AS VASOPRESSIN AND/OR OCYTOCINE AGONISTS AND/OR ANTAGONISTS SANOFI (FR) 1995-07-06 WO disclosed
US-5064963-A CONTROLLING PH DURING REACTION AMERICAN CYANAMID COMPANY (US) 1991-11-12 US disclosed
EP-0453731-A2 Improved process for the synthesis of N-3-(1H-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidinamines AMERICAN CYANAMID COMPANY (US) 1991-10-30 EP disclosed